Agios Pharmaceuticals Inc. (AGIO)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
Q3  2021 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 26,960 | 0.01 | |
Q1  2021 | |||||
≡ | Lee Ainslie - Maverick Capital | Add 1270.17% | 3,747 | 0.00 | |
Q4  2020 | |||||
≡ | Lee Ainslie - Maverick Capital | Buy | 295 | 0.00 | |
Q4  2018 | |||||
≡ | Meridian Contrarian Fund | Add 18.42% | 21,000 | 0.19 | |
Q1  2018 | |||||
≡ | Leon Cooperman | Buy | 45,000 | 0.14 | |
Q3  2017 | |||||
≡ | Meridian Contrarian Fund | Add 9.60% | 12,000 | 0.14 | |
Q1  2017 | |||||
≡ | Meridian Contrarian Fund | Add 100.00% | 62,500 | 0.70 | |
Q2  2016 | |||||
≡ | Meridian Contrarian Fund | Add 42.02% | 25,000 | 0.21 | |
Q4  2015 | |||||
≡ | Meridian Contrarian Fund | Buy | 59,500 | 0.71 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.